The Global Parkinson’s Disease Market is anticipated to grow at a compound annual growth rate ( CAGR ) of 5.5% during 2020-2026 while it was close to USD 4.5 BN in 2019. The market will outgrow to USD 6.6 BN by 2026 as per the research conducted by Value Market Research. Parkinson's disease treatment includes drugs such as levodopa along with carbidopa to increase levels of dopamine, deep brain stimulation, and other therapies. The significant growth of Parkinson's disease treatment market owes to the rising geriatric population, growing prevalence of Parkinson's disease, and increasing incidences of central nervous system disorders at an early age. Moreover, growing Research and Development in Parkinson's disease and its treatment is further supporting the market. During COVID-19, Pandemic, the global market is expected to drive steadily but slowly as the entire healthcare market has focused on developing the vaccine against the Pandemic.
Parkinson's disease, a condition of the central nervous system, leading to difficulty in walking, stiffness, shaking, difficulty in balancing, and coordination. The disease progresses gradually and leads to difficulty in talking, sleep disorders, fatigue, memory difficulties, and behavioral changes. Generally, the condition gets developed at about 60, and men are more prone to this brain disorder. The cause of Parkinson's disease is damaging nerve cells or neurons in the brain that controls movement. When nerve cells get damaged, the production of the vital brain chemical dopamine gets hampered. Dopamine is involved in motor control and acts as a neurotransmitter that sends signals to nerve cells.
"Global Parkinson’s Disease Market Report By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" report begins with the market introduction, market snapshot followed by in-depth regional revenue/volume for the next six years. The geo-economic factors and historic parkinson’s disease industry trends are analysed to foresee and predict the forecasts for next six years.
On the basis of Drug Class the market is segmented into Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs. By Distribution Channel the parkinson’s disease market is categorised as Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies. By Patient Care Setting the parkinson’s disease market is categorised as Hospitals, Clinics.The geographical segmentation of the report highlights the share of the revenue/volume spread globally as per region and country. The study in segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
The Report Segments Global Parkinson’s Disease Market -
By Drug Class
- Levodopa/carbidopa
- Dopamine Receptor Agonists
- MAO-Inhibitors
- COMT-inhibitors
- Anticholinergics
- Other Drugs
By Distribution Channel
- Hospital Pharmacies
- Retailer Pharmacies
- Online Pharmacies
By Patient Care Setting
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, UCB, Valeant Pharmaceuticals, Acadia, Sun Pharma, Wockhardt, Dr. Reddy’s, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, Upsher-Smith.
Download the FREE SAMPLE of Global Parkinson’s Disease Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: sales@valuemarketresearch.com
Website: https://www.valuemarketresearch.com